deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01590433

Weight Loss With Exenatide Treatment

A Prospective Study of Patterns, Predictors, and Mechanisms of Weight Loss With Exenatide Treatment in Overweight and Obese Women Without Diabetes

Sponsor: AstraZeneca

Conditions Obesity
Interventions Dietary counseling Exenatide Placebo
Updated 15 times since 2017 Last updated: Jun 18, 2021 Started: Mar 31, 2012 Primary completion: Jan 31, 2019 Completion: Jan 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obesity, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 15 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Dec 2017 · 8 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Apr 2019 · 5 months · monthly snapshot~Apr 2019 – ~Oct 2019 · 6 months · monthly snapshot~Oct 2019 – ~Mar 2020 · 5 months · monthly snapshot~Mar 2020 – ~Jun 2020 · 3 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE4

  5. Jun 2020 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

▶ Show 10 earlier versions

  1. Mar 2020 — Jun 2020 [monthly]

    Active Not Recruiting PHASE4

  2. Oct 2019 — Mar 2020 [monthly]

    Active Not Recruiting PHASE4

  3. Apr 2019 — Oct 2019 [monthly]

    Active Not Recruiting PHASE4

  4. Nov 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE4

  5. Aug 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE4

  6. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE4

  7. Dec 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting · Phase: NA → PHASE4

  8. Apr 2017 — Dec 2017 [monthly]

    Recruiting NA

  9. Feb 2017 — Apr 2017 [monthly]

    Recruiting NA

  10. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Jody Dushay
Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations